Differential β-adrenoceptor expression induced by nerve growth factor infusion into the canine right and left stellate ganglia

Heart Rhythm

Volumn 2, Issue 12, 2005, Pages 1347-1355

  Zhou, Shengmei ^a   Paz, Offir ^a   Cao, Ji Min ^a   Asotra, Kamlesh ^a   Chai, Ning Ning ^b   Wang, Charles ^b   Chen, Lan S ^c   Fishbein, Michael C ^d   Sharifi, Behrooz ^a   Chen, Peng Sheng ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b OMC Clinical Research Center   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arrhythmia; Death, sudden; Nervous system, sympathetic; Receptors, adrenergic, beta

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; MESSENGER RNA; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RNA ANALYSIS; STELLATE GANGLION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HEART BLOCK; HEART VENTRICLES; INFUSION PUMPS, IMPLANTABLE; MYOCARDIAL INFARCTION; MYOCARDIUM; NERVE GROWTH FACTOR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; STELLATE GANGLION; TACHYCARDIA, VENTRICULAR; UP-REGULATION;

EID: 30344444493     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.08.027     Document Type: Article

References (32)

1. A.J., Kaumann P. Molenaar Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355: 1997; 667-681.
2. N., Freemantle J., Cleland P., Young J., Mason J. Harrison beta Blockade after myocardial infarction: Systematic review and meta regression analysis. Brit Med J 318: 1999; 1730-1737.
3. S.S., Gottlieb R.J., McCarter R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339: 1998; 489-497.
4. C., Gauthier G., Tavernier F., Charpentier D., Langin H. Le Marec Functional beta3-adrenoceptor in the human heart. J Clin Invest 98: 1996; 556-562.
5. H.J., Cheng Z.S., Zhang K., Onishi T., Ukai D.C., Sane C.P. Cheng Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ Res 89: 2001; 599-606.
6. J.P. Giacobino Beta 3-adrenoceptor an update. Eur J Endocrinol 132: 1995; 377-385.
7. C., Gauthier D., Langin J.L. Balligand Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21: 2000; 426-431.
8. J.-M., Cao L.S., Chen B.H., KenKnight T., Ohara M.-H., Lee J., Tsai W.W., Lai H.S., Karagueuzian P.L., Wolf M.C., Fishbein P.-S. Chen Nerve sprouting and sudden cardiac death. Circ Res 86: 2000; 816-821.
9. S., Zhou J.M., Cao Z.D., Tebb T., Ohara H.L., Huang C., Omichi M.H., Lee B.H., KenKnight L.S., Chen M.C., Fishbein H.S., Karagueuzian P.-S. Chen Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol 12: 2001; 1068-1073.
10. S., Moniotte L., Kobzik O., Feron J.N., Trochu C., Gauthier J.L. Balligand Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103: 2001; 1649-1655.
11. H.N., Pak M., Qayyum D.T., Kim A., Hamabe Y., Miyauchi M.C., Lill M., Frantzen K., Takizawa L.S., Chen M.C., Fishbein B.G., Sharifi P.S., Chen R. Makkar Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a swine model of myocardial infarction. J Cardiovasc Electrophysiol 14: 2003; 841-848.
12. D.M., Barry J.S., Trimmer J.P., Merlie J.M. Nerbonne Differential expression of voltage-gated K + channel subunits in adult rat heart. Relation to functional K + channels? Circ Res 77: 1995; 361-369.
13. S., Zhou L.S., Chen Y., Miyauchi M., Miyauchi S., Kar S., Kangavari M.C., Fishbein B., Sharifi P.S. Chen Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95: 2004; 76-83.
14. S., Rathi S., Kazerounian K., Banwait S., Schulz S.A., Waldman S. Rattan Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter. J Pharmacol Exp Ther 305: 2003; 615-624.
15. Y.T., Shen P., Cervoni T., Claus S.F. Vatner Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J Pharmacol Exp Ther 278: 1996; 1435-1443.
16. T.A., Kohout H., Takaoka P.H., McDonald S.J., Perry L., Mao R.J., Lefkowitz H.A. Rockman Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104: 2001; 2485-2491.
17. G., Tavernier G., Toumaniantz M., Erfanian M.F., Heymann K., Laurent D., Langin C. Gauthier beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res 59: 2003; 288-296.
18. T., Kitamura K., Onishi K., Dohi T., Okinaka N., Isaka T. Nakano The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol 35: 2000; 786-790.
19. S.E. Harding Lack of evidence for 3-adrenoceptor modulation of contractile function in human ventricular myocytes. Circulation 96(Suppl 1) 1997; 1-53.
20. R.F., Bosch A.C., Schneck J., Kiehn W., Zhang A., Hambrock B.W., Eigenberger N., Rub J., Gogel C., Mewis L., Seipel V. Kuhlkamp beta(3)-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes. Cardiovasc Res 56: 2002; 393-403.
21. V., Leblais S., Demolombe G., Vallette D., Langin I., Baro D., Escande C. Gauthier beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem 274: 1999; 6107-6113.
22. U.D., Dincer K.R., Bidasee S., Guner A., Tay A.T., Ozcelikay V.M. Altan The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes 50: 2001; 455-461.
23. B.M., Heath J., Xia E., Dong R.H., An A., Brooks C., Liang H.J., Federoff R.S. Kass Overexpression of nerve growth factor in the heart alters ion channel activity and beta-adrenergic signalling in an adult transgenic mouse. J Physiol 512: 1998; 779-791.
24. M.R., Bristow W.A., Minobe M.V., Raynolds J.D., Port R., Rasmussen P.E., Ray A.M. Feldman Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92: 1993; 2737-2745.
25. R., Ihl-Vahl T., Eschenhagen W., Kubler R., Marquetant M., Nose W., Schmitz H., Scholz R.H. Strasser Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 28: 1996; 1-10.
26. W., Vleeming P.A., van der Wouw J.D., te Biesebeek H.H. van Rooij J., Wemer A.J. Porsius Density of beta adrenoceptors in rat heart and lymphocytes 48 hours and 7 days after acute myocardial infarction. Cardiovasc Res 23: 1989; 859-866.
27. A.J., Prahash S., Gupta I.S. Anand Myocyte response to beta-adrenergic stimulation is preserved in the noninfarcted myocardium of globally dysfunctional rat hearts after myocardial infarction. Circulation 102: 2000; 1840-1846.
28. O.E., Brodde M., Khamssi H.R. Zerkowski Beta-adrenoceptors in the transplanted human heart: Unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time. Naunyn Schmiedebergs Arch Pharmacol 344: 1991; 430-436.
29. H.M., Farrukh M., White J.D., Port D., Handwerger P., Larrabee J., Klein R.A., Roden L., Skerl D.G., Renlund A.M., Feldman M.R. Bristow Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts. J Am Coll Cardiol 22: 1993; 1902-1908.
30. C., Gauthier G., Tavernier J.N., Trochu V., Leblais K., Laurent D., Langin D., Escande H. Le Marec Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther 290: 1999; 687-693.
31. J., Nordengren B., Casslen B., Gustavsson M., Einarsdottir R. Willen Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma. Int J Cancer 79: 1998; 195-201.
32. K., Nakamura M., Ohyanagi T. Iwasaki Dissociation of beta-adrenoceptor numbers from mRNA levels during acute ischemia in rat myocardium. Jpn J Pharmacol 73: 1997; 23-28.